A Novel Polysaccharide Depolymerase Encoded by the Phage SH-KP152226 Confers Specific Activity Against Multidrug-Resistant Klebsiella pneumoniae via Biofilm Degradation
Новая полисахаридная деполимераза, кодируемая фагом SH-KP152226, обеспечивает специфическую активность против мультирезистентной Klebsiella pneumoniae посредством деградации биопленки
2019-12-02
SCID: 54.1/5ddsqfwd
Discuss with AI
K47 capsuleKlebsiella pneumoniaebiofilm degradationphage depolymerasepolymyxin combination therapy
Figures from the paper
Abstract (AI)
The increasing prevalence of infections by multidrug-resistant Klebsiella pneumoniae necessitates the development of alternative therapies. Here, we isolated, characterized and sequenced a K. pneumoniae bacteriophage (SH-KP152226), which specifically infects and lyses K. pneumoniae capsular type K47. Phage SH-KP152226 contains a genome of 41,420 bp that encodes 48 predicted proteins. Among them, Dep42, the gene product of ORF42, is a putative tail fiber protein and hypothetically possesses depolymerase activity. We demonstrated that recombinant Dep42 showed specific enzymatic activities on the depolymerization of the K47 capsule of K. pneumoniae and was able to significantly inhibit biofilm formation and/or degrade formed biofilms. We also showed that Dep42 could enhance polymyxin activity against K. pneumoniae biofilms through the combination of depolymerase and antibiotics. These results suggest that the identified novel depolymerase Dep42 encoded by phage SH-KP152226 combined with antibiotics may represent a promising strategy to combat infection by drug-resistant and biofilm-forming K. pneumoniae.
Key Findings
1
Combining Dep42 with polymyxin enhances antibiotic activity against K. pneumoniae biofilms, suggesting a strategy against multidrug-resistant infections.
2
Dep42 significantly inhibits biofilm formation and degrades established K. pneumoniae biofilms.
3
Phage SH-KP152226 specifically infects and lyses K47-capsule Klebsiella pneumoniae.
4
Recombinant Dep42 enzymatically depolymerizes the K47 capsule of K. pneumoniae.
5
The 41,420-bp phage genome encodes 48 predicted proteins, including Dep42, a putative tail fiber depolymerase.
Research Object
K47-capsulated multidrug-resistant Klebsiella pneumoniae and its biofilms
Research Subject
Dep42-mediated depolymerization of the K47 capsule, biofilm inhibition and degradation, and enhancement of polymyxin activity
Publication Details
Publication Date
2019-12-02
Journal
Publisher
ISSN
Cited by
183
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Cited by8
Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: A Review2022
Bacteriophage-Derived Depolymerases against Bacterial Biofilm2021
Translating bacteriophage-derived depolymerases into antibacterial therapeutics: Challenges and prospects2023
Phage-Derived Depolymerase as an Antibiotic Adjuvant Against Multidrug-Resistant Acinetobacter baumannii2022
Klebsiella phage KP34gp57 capsular depolymerase structure and function: from a serendipitous finding to the design of active mini-enzymes against K. pneumoniae2023
The Specific Capsule Depolymerase of Phage PMK34 Sensitizes Acinetobacter baumannii to Serum Killing2022
Novel Phage-Derived Depolymerase with Activity against Proteus mirabilis Biofilms2021
Specificity and diversity of Klebsiella pneumoniae phage-encoded capsule depolymerases2024